Diabeloop Unveils New DBLG2 Demo App: Experience the Future of Automated Insulin Delivery Simulation

GRENOBLE, France - July 1, 2026 - Diabeloop, a pioneer in therapeutic AI, today announced the launch of a new, highly ...
Zacks Investment Research on MSN

MiniMed launches Abbott's Instinct sensors across European markets

MiniMed MMED recently announced the commercial launch of its MiniMed 780G automated insulin delivery system integrated with Abbott Laboratories' ABT Instinct sensor and the MiniMed Go system ...

MiniMed launches Instinct sensors in Europe giving people with diabetes more sensor choice with the same proven outcomes

MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced the commercial launch in Europe of both the ...

MiniMed's Smallest App-Controlled Insulin Pump is Now Available in the U.S.

MiniMed (Nasdaq: MMED), today announced its first commercial launch of the MiniMed Flex™ system in the United States — its first app-controlled pump and the company's smallest insulin pump yet. The ...
Hosted on MSN

FDA approves new inhalable insulin treatment for kids with type 1 diabetes | Health Watch

The Food and Drug Administration has approved inhaled insulin for children with diabetes—the first needle-free option for kids. Senate reverses vote on Iran war after volatile meeting with Trump Iran ...
The Conversation

Why insulin, the core element of diabetes treatment remains inaccessible for millions of people

The discovery of insulin in 1921 revolutionised diabetes care. Type 1 diabetes went from being a death sentence to a manageable chronic condition. To ensure access to this vital medicine to as many ...
The Globe and Mail

Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website

IRVINE, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that near ...
The American Journal of Managed Care

FDA Approves Inhaled Insulin for Children, Adolescents With Diabetes

Label expansion enables a rapid-acting inhaled mealtime insulin option for pediatric patients ≥6 years, addressing injection burden amid persistent unmet needs in youth diabetes management.
Detroit Free Press

Michigan teen gets type 1 diabetes therapy to delay need for insulin

Grayson Visco, 14, of Hudsonville, was at high risk for developing type 1 diabetes. His father has the autoimmune disease, and that made Grayson a good candidate for screening. Testing showed he had ...
Healio

Continuing insulin pump therapy during hospitalization may improve glycemic outcomes

Please provide your email address to receive an email when new articles are posted on . Adults who continued using their insulin pump during hospitalization had higher time in range than those who ...
Business Wire

OpenEvidence Collaborates With NCCN to Integrate Canonical Oncology Treatment Algorithms at the Point-of-Care

MIAMI--(BUSINESS WIRE)--OpenEvidence now integrates National Comprehensive Cancer Network ® (NCCN ®) Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) directly in answers, grounding ...
Morningstar

OpenEvidence Collaborates With NCCN to Integrate Canonical Oncology Treatment Algorithms at the Point-of-Care

OpenEvidence now integrates National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) directly in answers, grounding responses in the pinnacle ...